Osamu Maeda

5.1k total citations
203 papers, 3.8k citations indexed

About

Osamu Maeda is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Osamu Maeda has authored 203 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Surgery, 66 papers in Pulmonary and Respiratory Medicine and 48 papers in Oncology. Recurrent topics in Osamu Maeda's work include Gastric Cancer Management and Outcomes (25 papers), Helicobacter pylori-related gastroenterology studies (19 papers) and Inflammatory Bowel Disease (19 papers). Osamu Maeda is often cited by papers focused on Gastric Cancer Management and Outcomes (25 papers), Helicobacter pylori-related gastroenterology studies (19 papers) and Inflammatory Bowel Disease (19 papers). Osamu Maeda collaborates with scholars based in Japan, United States and United Kingdom. Osamu Maeda's co-authors include Hidemi Goto, Naoki Ohmiya, Takafumi Ando, Kazuhiro Ishiguro, Yasumasa Niwa, Osamu Watanabe, Yoshiki Hirooka, Akihiro Ito, Yoshitaka Sekido and Kaoru Shimokata and has published in prestigious journals such as Applied Physics Letters, The Journal of Immunology and Gastroenterology.

In The Last Decade

Osamu Maeda

187 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Osamu Maeda Japan 33 1.3k 1.0k 794 748 544 203 3.8k
László Tiszlavicz Hungary 31 1.2k 0.9× 709 0.7× 709 0.9× 706 0.9× 226 0.4× 234 3.2k
Jean Closset Belgium 34 1.5k 1.1× 758 0.7× 738 0.9× 1.0k 1.3× 215 0.4× 158 3.8k
Hiroaki Murata Japan 35 1.0k 0.8× 1.2k 1.2× 1.1k 1.4× 657 0.9× 154 0.3× 223 4.0k
François Lanza France 51 1.2k 0.9× 1.5k 1.5× 1.1k 1.4× 437 0.6× 253 0.5× 195 7.1k
Junji Kato Japan 38 937 0.7× 1.7k 1.7× 707 0.9× 967 1.3× 204 0.4× 197 5.5k
Tsutomu Sato Japan 41 1.9k 1.4× 1.6k 1.6× 1.5k 1.9× 1.5k 2.0× 467 0.9× 382 6.5k
K. E. Britton United Kingdom 42 1.9k 1.4× 601 0.6× 1.0k 1.3× 835 1.1× 294 0.5× 218 5.6k
Satoru Kikuchi Japan 30 785 0.6× 780 0.8× 593 0.7× 823 1.1× 190 0.3× 153 2.8k
Walter L. Trudeau United States 30 1.1k 0.8× 662 0.7× 312 0.4× 453 0.6× 519 1.0× 82 3.2k
Takayuki Asao Japan 39 1.9k 1.4× 1.8k 1.7× 1.9k 2.4× 1.7k 2.3× 941 1.7× 302 6.0k

Countries citing papers authored by Osamu Maeda

Since Specialization
Citations

This map shows the geographic impact of Osamu Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osamu Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osamu Maeda more than expected).

Fields of papers citing papers by Osamu Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osamu Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osamu Maeda. The network helps show where Osamu Maeda may publish in the future.

Co-authorship network of co-authors of Osamu Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Osamu Maeda. A scholar is included among the top collaborators of Osamu Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osamu Maeda. Osamu Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ohno, Eizaburo, Takuya Ishikawa, Kentaro Yamao, et al.. (2023). Impact of sarcopenia on biliary drainage during neoadjuvant therapy for pancreatic cancer. Clinical Endoscopy. 57(1). 112–121. 3 indexed citations
3.
Nakanishi, Koki, Chie Tanaka, Mitsuro Kanda, et al.. (2023). Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer. Cancers. 15(21). 5197–5197. 3 indexed citations
4.
Yamamoto, Takafumi, Takanori Ito, Masatoshi Ishigami, et al.. (2022). Clustering using unsupervised machine learning to stratify the risk of immune‐related liver injury. Journal of Gastroenterology and Hepatology. 38(2). 251–258. 8 indexed citations
5.
Takano, Yuko, Sachi Morita, Megumi Inoue, et al.. (2021). P44-9 A case of recurrent gastric cancer with drug-induced immune thrombocytopenia caused by trastuzumab. Annals of Oncology. 32. S354–S354.
6.
Ishimura, Kosei, et al.. (2020). Approximated Completion Conditions of Kinematic Couplings for Precise Deployable Structures. TRANSACTIONS OF THE JAPAN SOCIETY FOR AERONAUTICAL AND SPACE SCIENCES AEROSPACE TECHNOLOGY JAPAN. 18(6). 369–374. 1 indexed citations
7.
Yamada, Suguru, Tsutomu Fujii, Yukihiro Yokoyama, et al.. (2018). Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer. Cancer Chemotherapy and Pharmacology. 81(5). 815–821. 20 indexed citations
8.
Ando, Yukio, Bishal Gyawali, Masami Matsumoto, et al.. (2015). Prophylactic Use of Antiemetics for Prevention of Opioid-Induced Nausea and Vomiting: A Questionnaire Survey among Japanese Physicians. Journal of Palliative Medicine. 18(11). 977–980. 5 indexed citations
9.
Matsuoka, Ayumu, Osamu Maeda, Eizaburo Ohno, et al.. (2015). FOLFIRINOX-induced reversible dysarthria: A case report and review of previous cases. Oncology Letters. 10(4). 2662–2664. 6 indexed citations
10.
Miyahara, Ryoji, Yoshiki Hirooka, Kohei Funasaka, et al.. (2014). Simplified magnetic anchor-guided endoscopic submucosal dissection in dogs (with videos). Gastrointestinal Endoscopy. 80(4). 712–716. 20 indexed citations
11.
Ujihara, Masaki, Takafumi Ando, Kazuhiro Ishiguro, et al.. (2013). Hepatic portal venous gas following colonoscopy in a patient with Crohn's disease.. Europe PMC (PubMed Central). 4 indexed citations
12.
Ando, Takafumi, Yuji Nishio, Osamu Watanabe, et al.. (2008). Value of colonoscopy for prediction of prognosis in patients with ulcerative colitis. World Journal of Gastroenterology. 14(14). 2133–2133. 11 indexed citations
13.
Maeda, Osamu, Takafumi Ando, Osamu Watanabe, et al.. (2006). DNA hypermethylation in colorectal neoplasms and inflammatory bowel disease: a mini review. Inflammopharmacology. 14(5-6). 204–206. 12 indexed citations
14.
Shinoda, Masataka, Kimihiro Saito, Tsutomu Ishimoto, et al.. (2005). High density near-field optical disc system. 4 indexed citations
15.
Danno, Katsuki, Masao Kameyama, Shingo Noura, et al.. (2004). Ileal Neobladder for Urinary Bladder Replacement in Case of Colorectal Carcinoma with Urinary Bladder Invasion. The Japanese Journal of Gastroenterological Surgery. 37(11). 1799–1804.
16.
Meguro, Norio, Osamu Maeda, Toshiaki Kinouchi, et al.. (1998). [Clinical significance of prostate specific antigen (PSA) and PSA density in the detection of T1a and T1b prostate cancer].. PubMed. 44(9). 639–43. 1 indexed citations
17.
Maeda, Osamu, Fumitaka Kikkawa, Koji Tamakoshi, et al.. (1997). A newly synthesized bifunctional inhibitor, CKA1083, enhances adriamycin activity against human ovarian carcinoma cells.. PubMed. 17(3C). 1985–92. 2 indexed citations
18.
Maeda, Osamu, Norio Meguro, Shinji Saiki, et al.. (1996). [Neoadjuvant endocrine therapy in patients with locally advanced prostate cancer].. PubMed. 42(10). 821–7. 1 indexed citations
19.
Kojima, Masayoshi, Fumitaka Kikkawa, Hidenori Oguchi, et al.. (1994). Potentiation of cis‐Diammine(1, 1‐cyclobutanedicarboxylato)platinum(II) by Amphotericin B in BALB/c Nude Mice Bearing Human Ovarian Carcinoma Cells. Japanese Journal of Cancer Research. 85(11). 1159–1164. 3 indexed citations
20.
Kikkawa, Fumitaka, M. Kojima, Osamu Maeda, et al.. (1993). Potentiating effect of amphotericin B on five platinum anticancer drugs in human cis-diamminedichloroplatinum (II) sensitive and resistant ovarian carcinoma cells.. PubMed. 13(4). 891–6. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026